Results 11 to 20 of about 16,718 (212)
Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia [PDF]
Медицинский совет, 2020 Mineral-bone disorder in chronic kidney disease (CKD-MBD) is one of the most important factor determining prognosis in dialysis patients. CKD-MBD syndrome occurs at the CKD stage 2 and reaches its maximum in patients with end-stage renal disease ...
A. M. Essaian, A. R. Rind
doaj +2 more sources
Review of the Literature: Severe Hyperphosphatemia
The American Journal of the Medical Sciences, 1995 A patient with a markedly elevated serum phosphorus level (23.9 mg/dL) is described, followed by a brief review of severe hyperphosphatemia. Elevated serum phosphorus levels may be artifactual or true. True hyperphosphatemia is usefully subdivided according to (a) whether phosphorus is added to the extracellular fluid from a variety of exogenous or ...
L, Thatte +5 more
openaire +3 more sources
Linchuang shenzangbing zazhi, 2020 Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease（CKD）,and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials（
WANG Shan-shan, WEN Tong, ZHANG Xin-zhou
doaj +1 more source
Spurious Hyperphosphatemia in a Patient with Multiple Myeloma: A Case Report [PDF]
, 2021 Spurious hyperphosphatemia has been reported periodically in multiple myeloma (MM) patients with paraproteinemia. It is important for clinicians to recognize this phenomenon in order to avoid misdiagnosis and unnecessary treatment for true ...
Rattana Leelawattana +1 more
core +1 more source
Hyperphosphatemia and Cardiovascular Disease [PDF]
Frontiers in Cell and Developmental Biology, 2021 Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range” are highly associated with increased cardiovascular disease risk and mortality in the general population and patients suffering from chronic kidney disease (CKD). As the kidney function declines, serum phosphate levels rise and subsequently induce the development of ...
Chao Zhou +4 more
openaire +3 more sources
Phosphate intake, hyperphosphatemia, and kidney function [PDF]
, 2022 Phosphate is essential in living organisms and its blood levels are regulated by a complex network involving the kidneys, intestine, parathyroid glands, and the skeleton.
Krapf, Reto +4 more
core +1 more source
Frontiers in Medicine, 2023 BackgroundHyperphosphatemia remains a major complication in patients with Continuous ambulatory peritoneal dialysis (CAPD) leading to increased morbidity and mortality. However, phosphorus management still has many challenges.ObjectiveThis study aimed to
Xiaojing Yin +3 more
doaj +1 more source
Pharmacology Research & Perspectives, 2022 Hyperphosphatemia associated with chronic kidney disease (CKD) not only dysregulates mineral metabolism and bone diseases, but also strongly contributes to the progression of kidney disease itself.
Yoshinori Tsuboi +7 more
doaj +1 more source
An update on tenapanor to treat hyperphosphatemia
, 2022 Hyperphosphatemia is a common feature in patients with chronic kidney disease (CKD), especially in those with end-stage renal disease (ESRD). Commonly, high serum phosphate levels are observed only in later stages of CKD. The control of hyperphosphatemia
Ciceri P. +6 more
core +1 more source
HYPERPHOSPHATEMIA IN END STAGE RENAL DISEASE: PREVALENCE AND PATIENTS CHARACTERISTICS OF MULTIETHNIC POPULATION OF UNITED ARAB EMIRATES [PDF]
, 2017 Objective: Hyperphosphatemia is significantly associated with increased mortality among end stage renal disease (ESRD) patients on hemodialysis. There is paucity of data on hyperphosphatemia in ESRD patients of the multiethnic population of United Arab ...
Syed Arman Rabbani +9 more
core +2 more sources